Min Jun 隶属于旧金山的 Crane Center for Transgender Surgery．他在纽约大学医学院与 Dr. Rachel Bluebond-Langner 进行了机器人辅助阴道成形术的进修。他提供 SRS 及 SRS 修复的手术服务。Min Jun 现时（2022 年 2 月）的手术地点位于 San Francisco Memorial Hospital．
Min Jun 所使用的技术为 Da Vinci 机器人辅助的腹膜阴道成形术。该技术从下腹开出 4-6 个 2cm 左右的刀口，并将机器人放进去，从腹部开始游离腹膜。他使用阴囊皮肤作为外部阴道皮肤以及阴唇皮肤；阴茎皮肤及龟头作为阴蒂附近的皮肤和阴蒂。这样的好处是因为阴蒂周围的皮肤得以保留，阴蒂的完整性和美观性可以得到增强。机器人接下来从内部缝合腹膜和皮肤的衔接部位，并完成手术。
- The mental health provider letter(s) must include ALL of the following:
- Patient’s legal and preferred name
- Patient’s date of birth
- Date provider/patient relationship began and the frequency of contact
- A statement that the patient has been diagnosed with persistent, well-documented gender dysphoria/gender identity disorder and exhibits all of the following:
- The desire to live and be accepted as a member of the opposite sex, usually accompanied by the wish to make his or her body as congruent as possible with the preferred sex through surgery and hormone treatment; and
- The transgender identity has been present persistently for at least two years; and
- The disorder is not a symptom of another mental health disorder; and
- The disorder causes clinically significant distress or impairment in social, occupational, or other important areas of functioning.
- Documentation that the patient has completed a minimum of 12 continuous months of living in a gender role that is congruent with their gender identity, across a wide range of life experience and events that may occur throughout the year.
- The patient has undergone a minimum of 12 continuous months of hormone therapy (recommended for bottom surgery and breast augmentation only).
- A statement that the patient has the capacity to make fully informed decisions and to consent for treatment.
- That the patient is able to comply with long term follow-up requirements and post- operative expectations have been addressed.
- If the patient has significant medical or mental health issues present, they must be reasonably well controlled.
- Any substance use (marijuana, alcohol, etc.) is well controlled for at least 6 months prior to the patient’s surgical date.
- The provider must state their experience with treating patients diagnosed with gender dysphoria.
- The letter from your Hormone Provider must include:
- Patient’s legal and preferred name
- Patient’s date of birth
- Date provider/patient relationship began and the frequency of contact
- Date hormone therapy began and the frequency of treatment
- That the patient has undergone a minimum of 12 continuous months of hormone replacement therapy
- If the patient has a contraindication to hormone therapy, please note this
